Screening for Lung Cancer

Lung cancer screening can find cancer early and save your life. Find out what it is, why it’s important, if you are eligible, and next steps.

Learn About Your Risk

From risk factors to how lung cancer develops, this section will provide you with a greater understanding of how and why lung cancer can develop.

Early Lung Cancer Screening

Who should be screened? How is screening done? Get the facts here, plus take the quiz to determine whether you are a candidate for lung cancer screening.

Understanding Your Results

Once your screening results are in, then what? In this section, you’ll learn about what the results may mean and how to take any next steps to care for yourself.

Latest News & Blogs

Latest Blog and News Animated characters looking at lung graphic

How is Lung Cancer Diagnosed?

The point at which lung cancer is diagnosed plays a key role in treatment and survival. The average 5-year survival rate for lung cancer diagnosed while still localized (stage I) is 61%. However, when it has spread to other organs of the body (such as the brain or liver) and is classified as

Latest Blog and News LUNGevity Announces Pierre Massion Young Investigator Awards for Early Detection Research

WASHINGTON, DC (March 23, 2023) – LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, is honored to announce the recipients of the Pierre Massion Young Investigator Award for Lung Cancer Early Detection Research.

Latest Blog and News People working on a clinical trial with equipment

Finding Clinical Trials for Lung Cancer: Tools and Resources

Clinical trials are an important option for patients because the newest treatment approaches, not available otherwise, are being tested in them. Clinical trial research leads to more advancements and potential treatment options, and the therapies used today were once tested in clinical trials

Latest Blog and News Logo for the targeted therapies of lung cancer meeting

Real-World Drug Development at the Targeted Therapies of Lung Cancer Meeting

The development of new treatments for any disease relies on the collaborative efforts of many different stakeholders, such as scientists, clinicians, patient advocacy groups, regulators, and pharmaceutical and biotech companies. During scientific conferences that happen throughout the year

Latest Blog and News Person getting groceries to help someone else

Emotional Care for the Whole Family

A diagnosis of cancer has an impact on the entire family. Emotional support from family and friends can make a significant difference to the experience of survivorship, but knowing when, how, and in what way to offer support can be a challenge to figure out. You may feel awkward and unsure

Latest Blog and News Headshot of Dr. Paik smiling

An Introduction to Squamous Cell Lung Cancer

Lung squamous cell carcinoma (LSCC), also called squamous cell lung cancer, is one of the major subtypes of non-small cell lung cancer (NSCLC). Fifty years ago, LSCC was the most common lung cancer diagnosis. LSCC was considered the classic smoker’s lung cancer, as most patients with LSCC had

Latest Blog and News Patient sitting with oncologist at table

Ask Your Oncologist the Right Questions

Communication is critical to a positive doctor-patient relationship. Knowing the right questions to ask helps ensure you leave your appointments with the information and answers you need. Being prepared may also lessen anxiety and help provide a sense of control. Meeting with your oncologist,

Latest Blog and News Caregiver looking and smiling at a loved one

For Caregivers: How to Support Your Loved One at Appointments

Doctors' appointments are critical junctures in your loved one's lung cancer journey. They are a time to gather information and ask questions. We have created a list of tips for caregivers so that you feel prepared for your loved one's appointments, especially if you are new to the role.

Latest Blog and News Close up photo of Dr. Iafrate

Innovative Research Brings Potential New Class of Drugs for Patients with ALK-EML4 Fusion

Targeted therapies, or treatments directed towards specific biomarkers in tumor cells, have been effective in treating many patients with advanced-stage non-small cell lung cancer (NSCLC). Tumors that have the ALK protein fused with another cancer-driving protein, such as the

Latest Blog and News Hand holding a world globe with white lung cancer ribbon

World Cancer Day and #CloseTheCareGap in Lung Cancer Screenings

For World Cancer Day this year, the Union for International Cancer Control presents the #CloseTheCareGap initiative. February 4, 2023 will be a day focused on promoting equity in the cancer space. The goal is to create best-case outcomes for all people diagnosed with cancer, regardless of race

Latest Blog and News In Partnership with Rising Tide Foundation, LUNGevity Issues RFA for $1.5M Lung Cancer Research Grant

WASHINGTON, DC (January 25, 2023) – LUNGevity Foundation is pleased to partner with Rising Tide Foundation, a global philanthropic organization based in Switzerland, to issue a Request for Application (RFA) to study how shared mechanisms of resistance can be targeted in oncogene-driven lung cancers.

Latest Blog and News EGFR Resisters Partners with LUNGevity to Issue RFA for Research into EGFR-Positive Lung Cancer

WASHINGTON, DC (January 25, 2023) – LUNGevity Foundation is honored to announce its second research partnership with the EGFR Resisters in issuing a Request for Application (RFA) for high-impact research focused on EGFR-positive lung cancer.

Support Our Work

Your support will help drive advances in lung cancer detection and treatment that are saving lives, and provide free education and support to all affected by lung cancer. Make a tax-deductible donation now, or fundraise with LUNGevity!

DONATE NOW